A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...

8 月 30 日～9 月 2 日，世界最具影响力的心血管学术会议——2024 年欧洲心脏病学会（ESC）年会于英国伦敦举行，此次 ESC 年会设置了 26 场最新科学研究专场（Late-Breaking Science）共 163 项研究、12 场 ...

A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said ...

Several studies revealed high cardiovascular risk in people with type 1 diabetes, including in those who are asymptomatic and ...

By improving triage, an artificial intelligence program could significantly aid emergency departments that are often ...

通常情况下，即使免疫系统处于“开窗期”，也不足以导致人生病。然而，如果在熬夜后进行高强度运动，这无疑就是让已经疲惫不堪的免疫系统雪上加霜，此时细菌、病毒等病原体也就更容易趁虚而入了。

Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...

The following is a summary of “Healthcare Resource Utilization Following Acute Myocardial Infarction Findings from RECORD-MI ...

Percutaneous coronary intervention (PCI) has proven lifesaving: Morbidity and mortality outcomes are significantly improved ...

JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction.